Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Smart Biopsy Devices Market CAGR Outlook And Future Development
The smart biopsy devices market has demonstrated strong growth in recent years. It is projected to expand from $3.01 billion in 2025 to $3.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to several factors, including increasing cancer incidence rates, the greater adoption of minimally invasive diagnostic procedures, the development of advanced imaging infrastructure, the rising prevalence of core needle biopsy techniques, and enhanced clinician training in image-guided diagnostics.
The smart biopsy devices market is anticipated to experience significant growth over the next few years. It is projected to reach $4.32 billion in 2030, progressing at a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is attributable to increasing demand for precision oncology diagnostics, rising investments in smart surgical technologies, the expansion of robotic-assisted intervention platforms, a growing focus on early disease detection, and the increasing integration of AI-driven diagnostic support. Prominent trends identified for this forecast period encompass increasing adoption of image-guided biopsy systems, rising use of robotic-assisted biopsy procedures, growing integration of real-time tissue feedback technologies, expansion of minimally invasive diagnostic techniques, and an enhanced focus on diagnostic accuracy and patient safety.
Get A Free Sample Report With In-Depth Market Insights:
Smart Biopsy Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing incidence of cancer is anticipated to drive growth in the smart biopsy devices market moving forward. Cancer is a broad category of illnesses that arises when abnormal cells proliferate uncontrollably within nearly any organ or tissue, extending beyond their normal boundaries to spread to other organs or invade adjacent body parts. The growing number of cancer cases has intensified the requirement for precise and focused tissue samples. This demand has spurred the creation and advancement of smart biopsy instruments, incorporating enhanced molecular, imaging, and precision capabilities to aid both diagnosis and treatment planning. For instance, in January 2024, the World Health Organization, an intergovernmental organization based in Switzerland, projected over 35 million new cancer cases by 2050. This marks a 77% rise from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Consequently, the escalating number of cancer cases is fueling the expansion of the smart biopsy device market.
Smart Biopsy Devices Market Segment Analysis And Revenue Potential
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Localization Wires
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
Smart Biopsy Devices Market Innovation Trends Shaping Future Development
Leading firms in the smart biopsy devices market are prioritizing the creation of sophisticated solutions, like multi-modality breast biopsy markers, to optimize lesion localization, ensure extended site visibility, and boost diagnostic certainty. These multi-modality markers are specifically designed biopsy site markers that maintain clear visibility across various imaging techniques, including ultrasound, mammography, and MRI, thereby assisting clinicians in precisely monitoring biopsy sites and facilitating accurate follow-up evaluations. As an illustration, in March 2024, Mammotome, a medical technology firm based in the U.S., introduced LumiMARK, its cutting-edge 510(k)-cleared breast biopsy site marker tailored for multi-modality identification. This marker, offered in three distinct 3D shapes—such as Tulip™ and Rose™—ensures consistent visibility across different imaging methods and delivers enhanced long-term detectability in both breast tissue and lymph nodes, contributing to more accurate diagnoses and continuous clinical decision-making.
Smart Biopsy Devices Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation
View The Full Smart Biopsy Devices Market Report:
Smart Biopsy Devices Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
